Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Clinical trial NCT07249840 · RECRUITING
Trial details
- NCT number
- NCT07249840
- Sponsor
- Brigham and Women's Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-24
- Primary completion
- 2030-08-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.